CN Patent

CN101175494B — 用于糖/脂质代谢异常的预防/治疗剂

Assigned to Tanabe Pharma Corp · Expires 2011-07-13 · 15y expired

What this patent protects

本发明提供用于治疗和/或预防与饮食相关的异常血液葡萄糖和脂质代谢的药剂，对于所述异常血液葡萄糖和脂质代谢还没有找到充分的治疗方法或治疗药物。

USPTO Abstract

本发明提供用于治疗和/或预防与饮食相关的异常血液葡萄糖和脂质代谢的药剂，对于所述异常血液葡萄糖和脂质代谢还没有找到充分的治疗方法或治疗药物。

Drugs covered by this patent

Patent Metadata

Patent number
CN101175494B
Jurisdiction
CN
Classification
—
Expires
2011-07-13
Drug substance claim
No
Drug product claim
No
Assignee
Tanabe Pharma Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.